John B Moriarty
CIK 1564621 · Chief Legal Officer · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RNA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
10578 SCIENCE CENTER DRIVE, SUITE 125
SAN DIEGO, CA 92121
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KARD | Chief Legal Officer | 47,784 | $12.74 | $608.8K | $0 | 1 | 2026-06-22 |
| Avidity Biosciences, Inc. (RNAM) Delisted | Chief Legal Officer | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Chief Legal Officer | 74,557 | $6.97 | $520.0K | -$252.8K | 5 | 2026-01-09 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Chief Legal Officer | 0 | $58.70 | $0 | $0 | 2 | 2024-01-23 |
| OLMA | EVP, Ch. Legal Officer & Sec. | — | $7.11 | — | $0 | 3 | 2023-02-02 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | EVP, General Counsel | 0 | — | — | $0 | 7 | 2020-07-02 |
Recent Filings · Page 4 of 6
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-05 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Tax (F) | −4,297 | -$143.6K | EDGAR |
| 2019-02-04 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Grant (A) | +18,750 | $0 | EDGAR |
| 2018-03-30 | PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2018-02-08 | — | Mixed | +24,626 | -$389.1K | |
| 2018-02-07 | — | Sell (S) | −1,261 | -$147.9K | |
| 2017-03-01 | — | Mixed | +4,696 | -$237.5K | |
| 2017-02-10 | — | Sell (S) | −167 | -$21.2K | |
| 2017-02-08 | — | Sell (S) | −3,538 | -$445.0K | |
| 2016-12-13 | — | Sell (S) | −1,044 | -$123.8K | |
| 2016-08-10 | — | Sell (S) | −135 | -$18.5K |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
13 sales · $1.65M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2023-07-18 | OLMA | 15,000 | $133.8K | $8.92 | 2023-07-20 |
| 2023-06-29 | OLMA | 7,500 | $71.2K | $9.50 | 2023-07-18 |
| 2023-06-28 | OLMA | 12,851 | $123.1K | $9.58 | 2023-06-29 |
| 2023-06-27 | OLMA | 15,029 | $133.3K | $8.87 | 2023-06-28 |
| 2023-06-15 | OLMA | 31 | $287 | $9.26 | 2023-06-27 |
| 2023-06-14 | OLMA | 198 | $1.8K | $9.29 | 2023-06-15 |
| 2023-06-13 | OLMA | 9,213 | $86.2K | $9.35 | 2023-06-14 |
| 2023-06-12 | OLMA | 41,167 | $365.0K | $8.87 | 2023-06-13 |
| 2023-06-09 | OLMA | 65,000 | $488.2K | $7.51 | 2023-06-12 |
| 2023-06-08 | OLMA | 15,000 | $93.0K | $6.20 | 2023-06-09 |
| 2023-06-06 | OLMA | 10,000 | $62.8K | $6.28 | 2023-06-08 |
| 2023-06-05 | OLMA | 10,023 | $60.4K | $6.03 | 2023-06-06 |
| 2023-05-19 | OLMA | 5,000 | $35.8K | $7.17 | 2023-06-05 |